as 02-13-2025 9:55am EST
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Founded: | 2008 | Country: | United States |
Employees: | N/A | City: | NEW YORK |
Market Cap: | 1.9B | IPO Year: | 2019 |
Target Price: | $20.83 | AVG Volume (30 days): | 1.8M |
Analyst Decision: | Buy | Number of Analysts: | 9 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.60 | EPS Growth: | 17.45 |
52 Week Low/High: | $13.39 - $42.08 | Next Earning Date: | 02-25-2025 |
Revenue: | $1,138,730,000 | Revenue Growth: | 10.24% |
Revenue Growth (this year): | 7.39% | Revenue Growth (next year): | 1.11% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Schlanger David J | PGNY | Executive Chairman | Dec 26 '24 | Buy | $14.68 | 150,000 | $2,202,330.00 | 228,269 | |
Anevski Peter | PGNY | CHIEF EXECUTIVE OFFICER | Dec 23 '24 | Buy | $14.48 | 209,500 | $3,034,083.75 | 441,463 |
PGNY Breaking Stock News: Dive into PGNY Ticker-Specific Updates for Smart Investing
MT Newswires
8 days ago
Argus Research
9 days ago
Zacks
10 days ago
Zacks
15 days ago
TipRanks
15 days ago
Argus Research
16 days ago
MT Newswires
16 days ago
GlobeNewswire
16 days ago
The information presented on this page, "PGNY Progyny Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.